Finoriq research workspace
BOSTON SCIENTIFIC CORP (BSX) Institutional Holdings & 13F Ownership
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in. Review BSX institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
- Company
- BOSTON SCIENTIFIC CORP (BSX)
- Ticker
- BSX
- Market Cap
- $65.3B
- Latest Price
- $43.91
- Industry
- Medical Devices
BOSTON SCIENTIFIC CORP (BSX) Top Institutional Holders
Top current 13F holders indexed for BOSTON SCIENTIFIC CORP (BSX). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Lee AinslieCIK 0000934639 | $263.2M | 3.0% | Filing2026-05-15 |
| 2 | Sands CapitalCIK 0001020066 | $46.2M | 0.18% | Filing2026-05-08 |
| 3 | Polen Capital ManagementCIK 0001034524 | $36.4M | 0.25% | Filing2026-05-14 |
| 4 | Joel GreenblattCIK 0001510387 | $30.3M | 0.09% | Filing2026-05-15 |
| 5 | Ken FisherCIK 0000850529 | $28.3M | 0.01% | Filing2026-05-05 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.